Fifth Third Bancorp
AMAG

Fifth Third Bancorp’s AMAG Pharmaceuticals AMAG Stock Holding History

Fifth Third Bancorp’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-93
Closed -$2K – 2391
2016
Q1 		$2K Sell
93
-24,273
-100% -$576K ﹤0.01% 2199
2015
Q4 		$736K Buy
24,366
+14,828
+155% +$479K 0.01% 618
2015
Q3 		$379K Buy
9,538
+1,118
+13% +$69.4K ﹤0.01% 805
2015
Q2 		$581K Buy
+8,420
New +$530K 0.01% 714

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Fifth Third Bancorp's AMAG Position: Q2 2016 in Review

Fifth Third Bancorp sold out of AMAG Pharmaceuticals (AMAG) in Q2 2016, closing a stake of 93 shares — an estimated $2K sold.

Fifth Third Bancorp first reported a position in AMAG in Q2 2015 and held it in 4 quarters. The position peaked at $736K in Q4 2015. 165 funds tracked by Wall St. Rank hold AMAG as of Q2 2016.

  • Fifth Third Bancorp reported no remaining AMAG Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Fifth Third Bancorp sold 93 AMAG Pharmaceuticals shares in Q2 2016, an estimated $2K.
  • Fifth Third Bancorp first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Fifth Third Bancorp's AMAG Pharmaceuticals position peaked at $736K in Q4 2015.
  • 165 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2016.

Based on Fifth Third Bancorp's 13F filing for Q2 2016, filed 11 Aug 2016.